Intrinsiqs

Is Pro-Dex, Inc. overvalued?

Pro-Dex, Inc. (PDEX) looks overvalued — trading about 29% above its fair value.

Overvalued
Current price $67.02 Fair value $47.27
Price
$67.02
Fair value
$47.27
Current P/E
23.6
Normal P/E
16.6
Market cap
$214.0M
Dividend yield
0.0%
Return on equity
29.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PDEX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.